Vaccines Articles
From the eradication of smallpox to the potential development of a preventive vaccine for AIDS, immunization is a lifesaving innovation that has proven to be the most transformative public health achievement of the 20th century.
Traditionally used as a preventive measure against a variety of diseases, vaccines are now being used to diagnose immune-deficient patients, and research is being conducted to use vaccines to treat immune and autoimmune diseases.
The progress made to improve vaccination rates around the world is astounding, made possible through the cooperation and funding of many organizations, but much still needs to be done to decrease or eradicate vaccinepreventable diseases
To secure a federal grant, researchers must navigate a rigorous and long application process. But, when completed properly, those projects deemed most likely to have an impact on the nation’s health do get funded.
New research comparing the new Fluzone High-Dose vaccine and the seasonal flu vaccine sheds light on how ineffective the latter vaccine has been for the elderly.
From identifying the strain to prioritizing high-risk recipients, a look at lessons learned from the development and distribution of the H1N1 vaccine.
Vaccines to treat pre-existing conditions have the potential to radically change medical treatment, and there’s renewed hope that therapeutic vaccines might soon be available to treat various diseases.
The search for a preventive and therapeutic vaccine for HIV has long been studied. A look at past and current research shows just how far we’ve come.
Providers hoping to counteract the anti-vaccine movement can cultivate trust by setting aside time for vaccine discussions and using effective, empathetic communication to encourage vaccine compliance.
On the cutting edge of innovation in the biopharmaceuticals marketplace, manufacturers are developing new vaccines against diseases for which there is a critical need, as well as improving existing vaccines.
As nearly obsolete diseases start staging a comeback and potential pandemics loom, it’s time to explore new practice and delivery models to boost vaccination rates across population lines
Debilitating illness and death are always tragic, but when disease is preventable by a readily available vaccine, the tragedy begs the questions: Were the affected individuals and their families aware of this vaccine-preventable disease, and was the vaccine required or recommended?